Insider Sheds Nearly 53,000 Shares of Consumer Health Stock, Valued at Almost $900,000

3 days ago 7

Jake Lerch, The Motley Fool

Thu, August 13, 2026 astatine 8:00 AM CDT 5 min read

Frederick Munsch, SVP, Controller and CAO of Bausch + Lomb Corporation (NYSE:BLCO), sold 52,900 shares of communal banal connected Aug. 10, 2026, according to a precocious disclosed SEC Form 4 filing.

Transaction summary

Transaction worth based connected SEC Form 4 weighted mean merchantability terms ($16.78); post-transaction worth based connected Aug. 10, 2026, marketplace adjacent ($16.83).

Company snapshot

  • Sector: Healthcare

  • Industry: Medical - Instruments & Supplies

  • Market Cap: $6.0 cardinal

  • Employees: 13,000

Bausch + Lomb Corporation is simply a planetary oculus wellness institution structured crossed segments, including Vision Care/Consumer Health, Ophthalmic Pharmaceuticals, and Surgical. The steadfast provides a portfolio ranging from interaction lenses and attraction products to nutritional supplements and surgical equipment.

Key questions

  • What was the magnitude of the transaction comparative to the insider's full equity stake?
    Frederick Munsch liquidated 54% of his nonstop communal banal position, selling 52,900 shares and retaining 45,831 shares aft the transaction.

  • How did the transaction terms comparison to caller marketplace levels?
    The merchantability was completed astatine a weighted mean terms of $16.78, portion the banal was priced astatine $16.87 arsenic of the Aug. 11, 2026, marketplace close.

  • What is the existent fiscal illustration of the firm?
    Bausch + Lomb Corporation reported trailing twelve-month gross of $5.3 cardinal and a nett income nonaccomplishment of -$171.0 million, according to the latest disposable data.

Company Overview

Company Snapshot

  • Bausch + Lomb operates arsenic a diversified planetary oculus wellness institution with 3 superior concern segments: Vision Care/Consumer Health, which generates gross done interaction lenses and attraction products; Ophthalmic Pharmaceuticals, which focuses connected medicine oculus medications; and Surgical, which provides surgical instruments and devices for ophthalmic procedures.

  • The company's concern exemplary centers connected delivering broad oculus wellness solutions crossed the consumer, pharmaceutical, and surgical markets, generating gross done merchandise sales, licensing arrangements, and work offerings to ophthalmologists, optometrists, and extremity consumers.

  • Bausch + Lomb serves a divers lawsuit base, including oculus attraction professionals, healthcare institutions, and consumers globally, with peculiar spot successful the interaction lens marketplace and established relationships with starring healthcare providers and retail organisation channels.

Read Entire Article